These results suggest that lncRNA-MALAT1 should be regarded as a cancer-related metastatic biomarker that can interfere with prevention treatments for cancer cell metastasis and provide a basis for further investigation of the mechanistic role of lncRNA-MALAT1 in various cancer phenotypes. The gene discussed is MALAT1; the disease is cancer.